BSX
Boston Scientific Corporation
Medical Devices · Healthcare · United States
42.69
close · 2026-10-29
value
74
cheaper than peers74
quality
88
stronger fundamentals88
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, latest year | 3.7% | 86 |
| forward P/E | 13.33× | 85 |
| cash flow yield, latest year | 4.5% | 77 |
| earnings yield, 1 year ago | 2.4% | 77 |
| earnings yield, 2 years ago | 2.1% | 77 |
| cash flow yield, 3 years ago | 1.2% | 68 |
| EV to EBITDA | 13.59× | 64 |
| cash flow yield, 2 years ago | 2.3% | 59 |
| cash flow yield, 1 year ago | 3.1% | 59 |
| price to book | 2.61× | 51 |
| earnings yield, 3 years ago | 0.9% | 50 |
| price to sales | 2.93× | 49 |
12 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 22.9% | 94 |
| return on equity | 15.3% | 86 |
| debt to equity | 50.2% | 53 |
| revenue growth | 7.5% | 51 |
4 of 4 measures available
Facts
| market cap | $62B |
| free cash flow | $2.45B |
| employees | 59,000 |
| first trade | 1992-05-19 |
| next earnings | 2026-10-28 |
| fundamentals updated | 2026-10-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 1.94 | 1.25 | 1.07 | 0.45 |
| free cash flow | $3.40B | $2.37B | $1.70B | $914.0M |
| net income | $2.90B | $1.85B | $1.59B | $698.0M |
| revenue | $20.07B | $16.75B | $14.24B | $12.68B |
| unusual items | -$232.0M | -$492.0M | -$174.0M | -$418.0M |